Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadine van Montfoort

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Cytokine & Growth Factor Reviews|September 22, 2014
Unmasking immune sensing of retroviruses: interplay between innate sensors and host effectorsNadine van Montfoort, David Olagnier, John Hiscott
Advances in Immunology|December 2, 2023
How B cells drive T-cell responses: A key role for cross-presentation of antibody-targeted antigensFerry Ossendorp, Nataschja I Ho, Nadine Van Montfoort
Cytokine & Growth Factor Reviews|August 30, 2020
Oncolytic virotherapy for pancreatic ductal adenocarcinoma: A glimmer of hope after years of disappointment?Evelyne Tassone, Michela Muscolini, Nadine van Montfoort, et al.
Cytokine & Growth Factor Reviews|February 2, 2023
Preexisting immunity: Barrier or bridge to effective oncolytic virus therapy?Christianne Groeneveldt, Jasper van den Ende, Nadine van Montfoort
Seminars in Cell & Developmental Biology|June 10, 2014
BDCA3(+)CLEC9A(+) human dendritic cell function and developmentEvelyn van der Aa, Nadine van Montfoort, Andrea M Woltman
International Journal of Molecular Sciences|May 27, 2023
The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic CancerImke Stouten, Nadine van Montfoort, Lukas J A C Hawinkels
Frontiers in Immunology|May 6, 2014
Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccinesNadine van Montfoort, Evelyn van der Aa, Andrea M Woltman
Human Vaccines & Immunotherapeutics|June 29, 2026
Repurposing licensed viral vaccines as anti-cancer therapeutics: Turning cold tumors hotDorine A de Bont, Maud Reugebrink, Nadine van Montfoort, et al.
Seminars in Immunology|September 24, 2025
Oncolytic virotherapy: Sparking durable anti-tumor immunity through microenvironment modulationChristoph F Kollmann, Nadine van Montfoort, Pierre Cordelier, et al.
Cancer Immunology, Immunotherapy : CII|November 5, 2008
Report on the sixth annual meeting of the Association for Immunotherapy of Cancer (CIMT), May 15 and 16, 2008 in Mainz, GermanyMarij J P Welters, Nadine van Montfoort, Selina Khan, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Cytokine & Growth Factor Reviews|September 22, 2014
Unmasking immune sensing of retroviruses: interplay between innate sensors and host effectorsNadine van Montfoort, David Olagnier, John Hiscott
Advances in Immunology|December 2, 2023
How B cells drive T-cell responses: A key role for cross-presentation of antibody-targeted antigensFerry Ossendorp, Nataschja I Ho, Nadine Van Montfoort
Cytokine & Growth Factor Reviews|August 30, 2020
Oncolytic virotherapy for pancreatic ductal adenocarcinoma: A glimmer of hope after years of disappointment?Evelyne Tassone, Michela Muscolini, Nadine van Montfoort, et al.
Cytokine & Growth Factor Reviews|February 2, 2023
Preexisting immunity: Barrier or bridge to effective oncolytic virus therapy?Christianne Groeneveldt, Jasper van den Ende, Nadine van Montfoort
Seminars in Cell & Developmental Biology|June 10, 2014
BDCA3(+)CLEC9A(+) human dendritic cell function and developmentEvelyn van der Aa, Nadine van Montfoort, Andrea M Woltman
International Journal of Molecular Sciences|May 27, 2023
The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic CancerImke Stouten, Nadine van Montfoort, Lukas J A C Hawinkels
Frontiers in Immunology|May 6, 2014
Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccinesNadine van Montfoort, Evelyn van der Aa, Andrea M Woltman
Human Vaccines & Immunotherapeutics|June 29, 2026
Repurposing licensed viral vaccines as anti-cancer therapeutics: Turning cold tumors hotDorine A de Bont, Maud Reugebrink, Nadine van Montfoort, et al.
Seminars in Immunology|September 24, 2025
Oncolytic virotherapy: Sparking durable anti-tumor immunity through microenvironment modulationChristoph F Kollmann, Nadine van Montfoort, Pierre Cordelier, et al.
Cancer Immunology, Immunotherapy : CII|November 5, 2008
Report on the sixth annual meeting of the Association for Immunotherapy of Cancer (CIMT), May 15 and 16, 2008 in Mainz, GermanyMarij J P Welters, Nadine van Montfoort, Selina Khan, et al.
Pageof 5